Skip to main content
. 2018 Oct 24;20:379–389. doi: 10.1016/j.redox.2018.10.013

Fig. 5.

Fig. 5

(A) U2OS cells stably expressing mt-roGFP were treated with different anticancer agents as indicated for 24 h. Cells were stained with Alexa 647- Annexin-V followed by FACS analysis of roGFP ratio against Annexin-V. (B). U2OS cells stably expressing mt-roGFP treated with different anticancer agents as indicated for 24 h after staining with TMRM as described. FACS analysis of roGFP against TMRM fluorescence was carried out.